Pensionfund DSM Netherlands decreased its position in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 10.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 135,719 shares of the real estate investment trust's stock after selling 15,000 shares during the quarter. Healthcare Realty Trust makes up 1.5% of Pensionfund DSM Netherlands' investment portfolio, making the stock its 21st largest position. Pensionfund DSM Netherlands' holdings in Healthcare Realty Trust were worth $2,294,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the stock. BNP Paribas Financial Markets purchased a new stake in shares of Healthcare Realty Trust in the 4th quarter valued at about $2,504,000. Cresset Asset Management LLC purchased a new position in shares of Healthcare Realty Trust during the 4th quarter valued at about $356,000. Deutsche Bank AG grew its position in Healthcare Realty Trust by 95.9% during the 4th quarter. Deutsche Bank AG now owns 464,941 shares of the real estate investment trust's stock worth $7,881,000 after acquiring an additional 227,566 shares during the last quarter. Focus Partners Wealth grew its position in shares of Healthcare Realty Trust by 23.5% in the 4th quarter. Focus Partners Wealth now owns 20,254 shares of the real estate investment trust's stock worth $352,000 after buying an additional 3,850 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new stake in shares of Healthcare Realty Trust in the 4th quarter worth approximately $45,000.
Healthcare Realty Trust Stock Up 1.4%
Shares of Healthcare Realty Trust stock traded up $0.25 on Thursday, hitting $18.21. 1,802,451 shares of the company were exchanged, compared to its average volume of 3,231,404. Healthcare Realty Trust Incorporated has a 1-year low of $14.09 and a 1-year high of $18.82. The stock has a market capitalization of $6.40 billion, a price-to-earnings ratio of -15.83 and a beta of 0.94. The company has a 50-day moving average price of $16.86 and a 200 day moving average price of $16.03.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $287.07 million for the quarter, compared to analyst estimates of $290.83 million. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.During the same quarter in the previous year, the company earned $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. Research analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.
Healthcare Realty Trust Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were paid a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 5.3%. The ex-dividend date was Thursday, August 14th. Healthcare Realty Trust's dividend payout ratio is currently -83.48%.
Wall Street Analysts Forecast Growth
HR has been the subject of a number of recent research reports. JPMorgan Chase & Co. lowered their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a research note on Thursday, June 26th. Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday, May 31st. Raymond James Financial lowered Healthcare Realty Trust from a "market perform" rating to an "underperform" rating in a research note on Monday. BTIG Research reiterated a "buy" rating and issued a $20.00 price target on shares of Healthcare Realty Trust in a report on Wednesday, September 10th. Finally, Wells Fargo & Company increased their target price on Healthcare Realty Trust from $15.00 to $16.00 and gave the company an "underweight" rating in a research report on Wednesday, August 27th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $17.67.
Get Our Latest Report on HR
Insider Buying and Selling at Healthcare Realty Trust
In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 10,000 shares of the firm's stock in a transaction dated Wednesday, August 13th. The stock was acquired at an average price of $16.46 per share, for a total transaction of $164,600.00. Following the completion of the purchase, the director owned 75,520 shares of the company's stock, valued at approximately $1,243,059.20. This represents a 15.26% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Julie F. Wilson sold 15,000 shares of the stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $18.00, for a total transaction of $270,000.00. Following the sale, the executive vice president owned 113,419 shares of the company's stock, valued at $2,041,542. This trade represents a 11.68% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company's stock.
Healthcare Realty Trust Company Profile
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Featured Articles

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.